Gilead Sciences to Participate in Two Upcoming Investor Conferences
February 08 2016 - 5:00PM
Business Wire
- 18th Annual BIO CEO &
Investor Conference -
- Leerink Partners 5th Annual
Global Healthcare Conference -
- Webcasts Available Through Gilead
Corporate Website -
Gilead Sciences, Inc. (Nasdaq: GILD) today announced webcasts
from two upcoming investor conferences: the 18th Annual BIO CEO
& Investor Conference and the Leerink Partners 5th Annual
Global Healthcare Conference, both taking place in New York.
John F. Milligan, PhD, Gilead’s President and Chief Operating
Officer, will participate in fireside chats at the BIO CEO
conference on Tuesday, February 9 at 2:00 p.m. Eastern Time (ET)
and the Leerink Partners conference on Wednesday, February 10 at
8:25 a.m. ET.
The live webcasts can be accessed at the company’s Investors
page at www.gilead.com/investors. Please connect to the company’s
website at least 15 minutes prior to the start of each fireside
chat to ensure adequate time for any software download that may be
required to listen to the webcast. The replays will be available
for 14 days following each webcast.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160208006066/en/
Gilead Sciences, Inc.Patrick O’Brien, 650-522-1936Investor
Relations
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024